Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by mumfordsenon Jan 01, 2018 4:14pm

63 Views

Post# 27257438

RE:RE:RE:Typical for guys who want in after weekend

bmeister2 wrote:
So true,justcamein, I wish those lowlife sorry-azz bashers would find another hobby and flock off like the birds.So sick of them ruining the boards with dribble.

It comes with the territory for most stocks that have made significant gains in such a short period of time. Instead of putting them on ignore, we need to make sure they don't distort the facts that would scare off new retail investors.

Bullboard Posts

Gold vs. bitcoin, where should you invest?